Episurf Medical AB (EPIS B) NPV B

Sell:0.12 SEKBuy:0.13 SEK0.01 SEK (4.89%)

Prices delayed by at least 15 minutes
Sell:0.12 SEK
Buy:0.13 SEK
Change:0.01 SEK (4.89%)
Prices delayed by at least 15 minutes
Sell:0.12 SEK
Buy:0.13 SEK
Change:0.01 SEK (4.89%)
Prices delayed by at least 15 minutes

Company Information

About this company

Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.

Key people

Pal Ryfors
Chief Executive Officer
Veronica Wallin
Chief Financial Officer
Patrick Jamnik
President of Episurf Medical Inc
Katarina Flodstrom
Chief Operating Officer
Fredrik Zetterberg
Marketing Director
Ulf Grunander
Independent Chairman of the Board
Leif Ryd
Director
Annette Brodin Rampe
Independent Director
Christian Krueger
Independent Director
Laura F. Shunk
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Sweden
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    SE0003491562
  • Market cap
    SEK 82.55m
  • Employees
    26
  • Shares in issue
    651.00m
  • Exchange
    Stockholm Stock Exchange
  • Index
    SX All Share PI Market Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.